Axonis Revenue and Competitors
Estimated Revenue & Valuation
- Axonis's estimated annual revenue is currently $6M per year.
- Axonis's estimated revenue per employee is $188,906
Employee Data
- Axonis has 32 Employees.
- Axonis grew their employee count by 23% last year.
Axonis's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Staff | Reveal Email/Phone |
4 | Chief Staff | Reveal Email/Phone |
5 | Chief Scientific Officer & Co-Founder | Reveal Email/Phone |
6 | Senior Scientist & Team Lead, Assay Development | Reveal Email/Phone |
7 | Principal Investigator |Translational Neuroscience | Reveal Email/Phone |
8 | Research Associate | Reveal Email/Phone |
Axonis Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Axonis?
AXONIS Therapeutics is advancing breakthrough drug discovery to develop groundbreaking therapies for spinal cord injury, and other currently incurable neurological disorders, making a real difference for patients, their families, and global healthcare system.
keywords:N/AN/A
Total Funding
32
Number of Employees
$6M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Axonis News
2022-04-13 - NOW HIRING: 8 Valley companies hiring NOW (04/17)
Axon is now hiring for remote roles in Sales, Engineering, and more. Check out their open positions here and apply today. 5. Door Sales &...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.4M | 32 | -47% | $124.9M |
#2 | $3.7M | 32 | -20% | N/A |
#3 | $2.5M | 32 | 0% | $226.9M |
#4 | $3.7M | 32 | N/A | N/A |
#5 | $3.7M | 32 | N/A | N/A |